DRUG ACCESS REQUESTS FOR INNOVATIVE THERAPIES FOR PEDIATRIC ONCOLOGY PATIENTS IN CANADA

被引:0
|
作者
Judd, Sandra [1 ]
Revon-Riviere, Gabriel [2 ]
Deyell, Rebecca J. [3 ]
Vanan, Magimairajan Issai [4 ]
Pecheux, Lucie [5 ]
Zorzi, Alexandra P. [6 ]
Santiago, Raoul [7 ]
Tran, Thai Hoa [8 ]
Grover, Stephanie A. [9 ]
Cohen-Gogo, Sarah [2 ]
Morgenstern, Daniel [2 ]
机构
[1] Hosp Sick Children, Dept Pharm, Toronto, ON, Canada
[2] Univ Toronto, Hosp Sick Children, Temerty Fac Med, Peditat Hematol Oncol, Toronto, ON, Canada
[3] Univ British Columbia, British Columbia Childrens Hosp, Pediat, Div Pediat Hematol Oncol Bmt, Vancouver, BC, Canada
[4] Univ Manitoba, Canc Care Manitoba Pediat & Child Hlth, Winnipeg, MB, Canada
[5] Univ Alberta, Stollery Childrens Hosp, Pediat Hematol Oncol, Edmonton, AB, Canada
[6] Childrens Hosp, London Hlth Sci Ctr, Pediat, London, ON, Canada
[7] Laval Univ, CHU Quebec, Pediat, Laval, PQ, Canada
[8] CHU St Justine, Pediat, Montreal, PQ, Canada
[9] Hosp Sick Children, Genet & Genome Biol, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP365
引用
收藏
页码:S317 / S318
页数:2
相关论文
共 50 条
  • [21] Religiosity is associated with the use of complementary medical therapies by pediatric oncology patients
    McCurdy, EA
    Spangler, JG
    Wofford, MM
    Chauvenet, AR
    McLean, TW
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (02) : 125 - 129
  • [22] Securing Access to Innovative Anticancer Therapies for Children, Adolescents and Young Adults Outside Clinical Trials: Sacha Study of The French Society of Pediatric Oncology (SFCE)
    Berlanga, P.
    Ndounga-Diakou, L. A.
    Corradini, N.
    Ducassou, S.
    Strullu, M.
    De Carli, E.
    Andre, N.
    Entz-Werle, N.
    Defachelles, A. -S.
    Roumy, M.
    Valteau-Couanet, D.
    Gandemer, V.
    Laghouati, S.
    Vassal, G.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S319 - S320
  • [23] Securing access to innovative anticancer therapies for children, adolescents, and young adults outside clinical trials: The SACHA study of the French Society of Pediatric Oncology (SFCE).
    Berlanga, Pablo
    Ndounga-Diakou, Lee Aymar
    Corradini, Nadege
    Ducassou, Stephane
    Strullu, Marion
    De Carli, Emilie
    Andre, Nicolas
    Entz-Werle, Natacha
    Defachelles, Anne Sophie
    Roumy, Marianne
    Valteau-Couanet, Dominique
    Gandemer, Virginie
    Laghouati, Salim
    Vassal, Gilles
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] INVISIBLE LEVER FOR ACCESS TO INNOVATIVE THERAPIES IN BULGARIA
    Dobreva, D. P.
    Petrova, T.
    VALUE IN HEALTH, 2016, 19 (07) : A719 - A719
  • [25] Canada's path towards proteome guided therapies and advanced molecular pathology in pediatric precision oncology
    Barnabas, Georgina
    Bhat, Tariq
    Goebeler, V.
    Leclair, P.
    Maxwell, C.
    Reid, G.
    Senger, D. L.
    Chan, J. A.
    Azzam, N.
    Melong, N.
    Berman, J. N.
    Parker, S.
    Bush, J.
    Strahlendorf, C.
    Deyell, R.
    Lim, C. J.
    Lange, Philipp F.
    CANCER RESEARCH, 2024, 84 (17)
  • [26] The use of herbal therapies in pediatric oncology patients: Treating symptoms of cancer and side effects of standard therapies
    Quimby, Erin L.
    JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2007, 24 (01) : 35 - 40
  • [27] Caregivers' Perception of Drug Administration Safety for Pediatric Oncology Patients
    Harris, Nariman
    Badr, Lina Kurdahi
    Saab, Raya
    Khalidi, Aziza
    JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2014, 31 (02) : 95 - 103
  • [28] Evaluation of potential drug interactions in hospitalized pediatric oncology patients
    Ribeiro, Emanuella de Souza
    Batista de Lacerda Pedrosa, Sybelle Christianne
    MUNDO DA SAUDE, 2021, 45 (01): : 34 - 44
  • [29] THE ROLE OF VENOUS ACCESS IN PEDIATRIC ONCOLOGY
    Rykov, M.
    Polyakov, V.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S390 - S391
  • [30] Totally implantable vascular access devices in 131 pediatric oncology patients
    Sola, JE
    Stone, MM
    Colombani, PM
    PEDIATRIC SURGERY INTERNATIONAL, 1996, 11 (2-3) : 156 - 158